1. "2009"
Formats
  1. Journal Article (1884)
  2. Meeting Abstract (566)
  3. Book Section (195)
  4. Conference Paper (22)
  5. Book Whole (16)
Groups
  1. Department of Medicine (784)
  2. Surgery (698)
  3. GSK Faculty (533)
  4. Sloan Kettering Institute Faculty (480)
  5. Solid Tumor Oncology Division (413)
  6. Survivorship Research (335)

More Groups

People
  1. Dennis Chi (53)
  2. Richard Barakat (51)
  3. Peter Scardino (47)
  4. Nadeem Abu-Rustum (44)
  5. Valerie Rusch (44)
  6. Yuman Fong (41)

More People

Years
  1. 2009 (2683)
Publications
  1. Journal of Clinical Oncology (219)
  2. Cancer Research (84)
  3. Blood (82)
  4. Gynecologic Oncology (64)
  5. Cancer Rehabilitation: Principles and Practice. 1st ed (51)
  6. Journal of Thoracic Oncology (44)

More Publications

Publishers
  1. Elsevier Inc. (297)
  2. American Society of Clinical Oncology (222)
  3. Elsevier Science, Inc. (164)
  4. Lippincott Williams & Wilkins (144)
  5. American Association for Cancer Research (143)
  6. Springer (137)

More Publishers

Results (2683)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical activity observed in a phase I dose escalation trial of an oral c-met and ALK inhibitor, PF-02341066
    Meeting Abstract

    Kwak, E. L.; Camidge, D. R.; Clark, J.; Shapiro, G. I.; Maki, R. G.; Ratain, M. J.; Solomon, B.; Bang, Y.; Ou, S.; Salgia, R.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in patients with light-chain amyloidosis (AL)
    Meeting Abstract

    Landau, H. J.; Hoffman, J.; Hassoun, H.; Elizabeth, H.; Riedel, E.; Nimer, S. D.; Cohen, A.; Comenzo, R. L.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Comparison of cisplatin (CDDP) and radiation (RT) to cetuximab (C) and RT for locally advanced head and neck cancer (LAHNC): A preliminary analysis
    Meeting Abstract

    Koutcher, L.; Fury, M.; Wolden, S.; Zhang, Z.; Mo, Q.; Zelefsky, M.; Kraus, D.; Sherman, E.; Pfister, D.; Lee, N.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • The prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced stage epithelial ovarian cancer
    Meeting Abstract

    Kolev, V.; Mironov, S.; Mironov, O.; Moskowitz, C.; Ishill, N. M.; Gardner, G. J.; Levine, D. A.; Hricak, H.; Barakat, R. R.; Chi, D. S.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Prevention of hip fractures in older men receiving androgen deprivation therapy for prostate cancer: A cost-effectiveness analysis
    Meeting Abstract

    Ito, K.; Elkin, E.; Morris, M.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Residual pathologic stage at radical cystectomy and risk stratification of patients with pT2N0 bladder cancer
    Meeting Abstract

    Isbarn, H.; Sonpavde, G.; Shariat, S. F.; Palapattu, G. S.; Sagalowsky, A. I.; Lotan, Y.; Schoenberg, M. P.; Amiel, G. E.; Lerner, S. P.; Karakiewicz, P. I.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Adequate lymph node assessment for extrahepatic bile duct cancer: Do the data support the current AJCC recommendations?
    Meeting Abstract

    Ito, K.; Ito, H.; Gonen, M.; Allen, P. J.; D'Angelica, M. I.; Fong, Y.; DeMatteo, R. P.; Blumgart, L. H.; Jarnagin, W. R.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Assessment of two dosing schedules of GSK1363089 (GSK089), a dual MET/VEGFR2 inhibitor, in metastatic gastric cancer (GC): Interim results of a multicenter phase II study
    Meeting Abstract

    Jhawer, M.; Kindler, H. L.; Wainberg, Z.; Ford, J.; Kunz, P.; Tang, L.; McCallum, S.; Kallender, H.; Shah, M. A.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase II trial of salirasib in patients with stage IIIB/IV lung adenocarcinoma enriched for KRAS mutations
    Meeting Abstract

    Johnson, M. L.; Rizvi, N. A.; Ginsberg, M. S.; Miller, V. A.; Kris, M. G.; Pao, W.; Riely, G. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase II trial of temozolomide (TMZ) followed by myeloablative chemotherapy with autologous peripheral blood progenitor cell rescue (APBPCR) for newly diagnosed anaplastic oligodendroglioma: An Oligodendroglioma Study Group trial
    Meeting Abstract

    Kaley, T. J.; Raizer, J. J.; Paleologos, N.; Kewalramani, T.; Grimm, S.; Louis, D. N.; Cairncross, J. G.; Abrey, L. E.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save